Oncolys BioPharma Inc. (TYO:4588)
7,410.00
-210.00 (-2.76%)
Nov 18, 2026, 10:45 AM JST
Oncolys BioPharma Market Cap
Oncolys BioPharma has a market cap or net worth of 218.95 billion as of November 17, 2026. It is the 7,945th most valuable company in the world and the 589th biggest in Japan. Its market cap has increased by 712.12% in one year.
Market Cap
218.95B
Enterprise Value
216.19B
Revenue
28.55M
Global Rank
Country Rank
#589 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 218.95B, an increase of 827.05%. That is a compound annual growth rate of 18.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 238.75B | 503.09% |
| Dec 30, 2025 | 39.59B | 207.33% |
| Dec 30, 2024 | 12.88B | 18.41% |
| Dec 29, 2023 | 10.88B | 19.14% |
| Dec 30, 2022 | 9.13B | -0.44% |
| Dec 30, 2021 | 9.17B | -58.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nxera Pharma | 165.14B |
| GNI Group | 149.19B |
| PeptiDream | 140.01B |
| Heartseed | 67.58B |
| SanBio Company | 65.10B |
| Cuorips | 53.82B |
| 3-D Matrix | 39.42B |
| Healios K.K. | 29.55B |